Cancer News and Research

Latest Cancer News and Research

Dendrimers improve imaging with magnetic nanoparticles

Dendrimers are spherical polymer nanoparticles that have shown promise as targeted anticancer drug delivery vehicles. Iron oxide nanoparticles have already demonstrated the ability to image tumors and metastatic lesions.

20 May 2008

Mass-producing tunable magnetic nanoparticles

Taking a cue from the semiconductor industry, a team of investigators at Stanford University has developed a method of producing unlimited quantities of highly magnetic nanoparticles suitable for use as magnetic resonance tumor imaging agents.

20 May 2008

Nanoparticle-induced heating boosts antitumor radiation therapy

Radiation therapy is a time-honored and effective component of modern cancer therapy, but its ultimate utility is limited by the fact that some cancer cells are resistant to ionizing radiation.

20 May 2008

Multifunctional nanoparticles image, target, and treat tumors

Encapsulating magnetic iron oxide nanoparticles within a silica shell has yielded a new multifunctional nanoparticle that has the potential to image, target, and treat tumors with water-insoluble anticancer drugs. A report of this work appears in the journal ACS Nano.

20 May 2008

Chip-based device measures drug resistance in tumor cells

Multiple drug resistance is a major cause of anticancer therapy failure. Most drug-resistance cancer cells develop this unfortunate characteristic due to a drug-pumping protein known as P-glycoprotein.

20 May 2008

New lifesaving options come to Rochester for stroke

While Superbowl Sunday started out like any other Sunday for Webster resident Christine Skolnick, by kick-off time, things clearly went from bad to worse for the 42-year-old mother of two. An apparent stomach virus and mild headache at midday had, by 6 p.m., become deadly, as Skolnick's face drooped on her right side, and she had difficulty moving her right legs and arms.

20 May 2008

Confused about HRT? read on!

As if women are not confused enough about the pros and cons of hormone replacement therapy (HRT), an international group of experts now say safety issues regarding HRT have been "over hyped".

20 May 2008

Breast cancer gene a culprit in prostate cancer

Australian researchers have discovered that a mutated version of the BRCA-2 gene known to lead to breast and ovarian cancer, is also a culprit in prostate cancer in men.

20 May 2008

HRT safe for healthy women entering menopause

HRT in the early postmenopausal period is safe, and healthy women going through the first few years of the menopause who need HRT to relieve symptoms should have no fears about its use. This is the conclusion and clinical advice of the First Global Summit on Menopause-Related Issues, which was held in Zurich on March 29th and 30th, 2008.

20 May 2008

Extinct Tasmanian tiger genes shown to function in a mouse

Researchers from the University of Melbourne, Australia, and the University of Texas, USA, have extracted genes from the extinct Tasmanian tiger (thylacine), inserted it into a mouse and observed a biological function - this is a world first for the use of the DNA of an extinct species to induce a functional response in another living organism.

20 May 2008

Bush Administration should 'rethink' immigration detention policies, editorial states

The "skyrocketing rate" of immigrants to the U.S. who are held in detention centers "is the result of an administration policy decision" to detain "all those who may be subject to deportation" and has led to "serious concerns about its ability to provide adequate care to this growing population because of staff shortages and budget shortfalls that inevitably lead to neglect or errors," a Washington Post editorial states.

19 May 2008

Radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus

Interim results from a nationwide clinical trial led by a University of North Carolina at Chapel Hill researcher suggest that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer.

19 May 2008

Cancer drug shows promise as treatment for pulmonary hypertension

A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension, researchers from the University of Chicago Medical Center report May 19 at the American Thoracic Society International Conference in Toronto, Canada.

19 May 2008

Mapping of prostate cancer genes opens the door to new treatments

Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments.

19 May 2008

Reliable genetic tests could predict lung cancer recurrence

The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers at Columbia University recently evaluated the ability of five high-risk genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose non-small cell lung cancer was caught early and surgically removed.

19 May 2008

Blood test for lung cancer

A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.

19 May 2008

Spectrum Pharmaceuticals to present data on Ortataxel in breast cancer at major oncology meeting

Spectrum Pharmaceuticals, Inc., will present Phase 2 data on ortataxel at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting being held May 30 to June 3, 2008 at the McCormick Place Convention Center in Chicago, Illinois.

19 May 2008

Two California health insurers agree to reinstate coverage for 1,200 people whose policies were rescinded after incurring high medical bills

California health insurers Kaiser Permanente and Health Net on Thursday agreed to reinstate coverage to about 1,200 individuals whose policies were improperly rescinded, the San Francisco Chronicle reports.

19 May 2008

Mobile phone use during pregnancy may increase child's risk of behavioural problems

Danish and American scientists suggest that using mobile phones while pregnant may increase the risk of the child developing problems such as hyperactivity.

19 May 2008

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer Research UK and Cancer Research Technology (CRT) - the charity's development and commercialisation arm - today announced an innovative new arrangement to progress into clinical development a potential anti-cancer compound from AstraZeneca.

19 May 2008